Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the management of type 2 diabetes. This man-made peptide duplicates the actions of naturally present GLP-1, a https://linkedbookmarker.com/story6407520/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes